Skip to main content
ICCM logo

ICCM · IceCure Medical Ltd.

Track ICCM — free
$3.02 +0.02 (+0.67%) At close · Aug 14
Market Cap
$10.35M
Shares
3.43M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$3.02 Open$3.04 Day$2.96–3.20 Since split$2.13–9.30 Avg vol 30d145K Short int38K · 1.1% float · 1.0d Short vol39% Last earningsAug 12, 2026 DataJun 2026–Aug 2026

Raw chart and full-history price indicators begin at the captured split on Jun 4, 2026; bars on opposite sides are not compared.

The closing range begins at the captured split on Jun 4, 2026.

Up next

Next earnings call
Nov 4, 2026 Est · unconfirmed · in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Limited Sentiment Neutral Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 14.3 · calm Equity put/call 0.52
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 50-day avg −23%
below
RSI (14) 43
neutral
MACD trend Positive
52-week position 12%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Limited
Not enough data for a confident read.
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Distributing
-39% holders QoQ · +2 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
1.10% of float · ▼ -66.3% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
11 holders — near 3-yr low, contrarian setup
Squeeze score 37
low risk · 0–100
Fundamentals
Weak
Revenue growth +3%
Y/Y
Gross margin 36%
contracting
EPS growth −20%
Y/Y
Free cash flow $-14.6M
Balance sheet $8.9M
net cash
Quant / Vol
risk profile
Very High
Volatility 495%
annualized · 1-yr
Max drawdown −70%
past year
ATR 14.8%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
2 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 50-day avg
−23% Bearish
RSI (14)
43 Neutral
MACD trend
Positive Bullish
52-week position
12% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Distributing
-39% holders QoQ · +2 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
1.10% of float · ▼ -66.3% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
11 holders — near 3-yr low, contrarian setup
Price context
position in its range since split · 2026-06-04
Range low $2 Now $3 · 12% Range high $9
vs 50-day avg -23%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ICCM
IceCure Medical Ltd.
this stock
$10.35M +2.7% 1.1%
ABT
Abbott Laboratories
$193.78B -11.2% +5.7% 31.2 1.3%
SYK
Stryker Corp
$130.11B -3.5% +11.2% 35.2 2.2%
MDT
Medtronic plc
$116.83B -5.0% +8.4% 24.5 1.4%
BSX
Boston Scientific Corp
$75.11B -45.6% +12.5% 21.0 1.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
11
% held
3.8%
Net QoQ
+23.0K sh
Top holder
ARMISTICE CAPITAL, LLC
Held Float
View
Short & Settlement
Short Interest Falling
Shares short
37.5K
Days to cover
1.0d
Change
-73.8K sh
View
Short Volume
Short vol %
39%
As of
Aug 14, 2026
Short Total
View
Fails to Deliver
FTD shares
8.0K
Value
$28.3K
As of
Jul 14, 2026
View
Off-Exchange
Off-exchange %
35.1%
Week of
Jul 6, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$3.4M
Net income (FY)
$-15.1M
EPS diluted
$7.20
View
Filings
SEC Filings
Latest
6-K
Filed
Aug 14, 2026
This year
31
View
Exempt Offerings
Offering
$16.5M
Filed
Jun 25, 2026
View
Earnings & Events
Earnings Calls
Last call
Aug 12, 2026
View

Performance

Raw-price comparisons begin at the captured split on Jun 4, 2026; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
ICCM -2.0% -17.3% +4.5%
SPY +0.4% +4.5% +13.8% +3.9% +13.9%
vs SPY -2.4% -21.7% +0.6%
Key facts CIK 1584371 CUSIP M53071201 13F (30d) 12 filings 12 filers Visit website Investor relations